NO20035331D0 - Nye heterocyklisk forbindelse og medisinsk anvendelse derav - Google Patents
Nye heterocyklisk forbindelse og medisinsk anvendelse deravInfo
- Publication number
- NO20035331D0 NO20035331D0 NO20035331A NO20035331A NO20035331D0 NO 20035331 D0 NO20035331 D0 NO 20035331D0 NO 20035331 A NO20035331 A NO 20035331A NO 20035331 A NO20035331 A NO 20035331A NO 20035331 D0 NO20035331 D0 NO 20035331D0
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic compounds
- medical use
- new heterocyclic
- new
- medical
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001161489 | 2001-05-29 | ||
| PCT/JP2002/005097 WO2002096880A1 (fr) | 2001-05-29 | 2002-05-27 | Nouveau compose heterocyclique et son utilisation medicinale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20035331D0 true NO20035331D0 (no) | 2003-11-28 |
| NO326688B1 NO326688B1 (no) | 2009-01-26 |
Family
ID=19004756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20035331A NO326688B1 (no) | 2001-05-29 | 2003-11-28 | Heterocyklisk forbindelse og anvendelse av denne, samt farmasoytisk sammensetning omfattende forbindelsen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7557123B2 (no) |
| EP (1) | EP1403253A4 (no) |
| JP (1) | JP4279136B2 (no) |
| KR (2) | KR20040030647A (no) |
| CN (1) | CN1242994C (no) |
| AR (1) | AR036036A1 (no) |
| AU (1) | AU2002308889B2 (no) |
| BR (1) | BR0209711A (no) |
| CA (1) | CA2448634A1 (no) |
| CO (1) | CO5540342A2 (no) |
| CZ (1) | CZ20033450A3 (no) |
| HU (1) | HUP0401862A3 (no) |
| IL (1) | IL159085A0 (no) |
| MX (1) | MXPA03010811A (no) |
| NO (1) | NO326688B1 (no) |
| NZ (1) | NZ530358A (no) |
| PL (1) | PL367639A1 (no) |
| RU (1) | RU2299197C2 (no) |
| TW (1) | TWI297008B (no) |
| WO (1) | WO2002096880A1 (no) |
| YU (1) | YU94003A (no) |
| ZA (1) | ZA200309757B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400023A2 (hu) | 2001-05-29 | 2004-04-28 | Kyoto Pharmaceutical Industries, Ltd. | Új heterociklusos származékok és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
| US7816385B2 (en) * | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
| WO2004106542A1 (ja) * | 2003-05-29 | 2004-12-09 | Sankyo Company, Limited | インスリン抵抗性改善剤及びそのスクリーニング方法 |
| TWI359810B (en) | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
| US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
| WO2007058504A1 (en) * | 2005-11-21 | 2007-05-24 | Lg Life Sciences, Ltd. | Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| RU2411936C2 (ru) * | 2009-01-11 | 2011-02-20 | Институт физиологии Коми научного центра Уральского отделения Российской академии наук. Государственное учреждение | Применение 2-морфолино-5-фенил-6н-1,3,4-тиадизин, гидробромида в качестве средства, обладающего гиполипидемическим и гипергликемическим эффектом |
| JPWO2012033195A1 (ja) * | 2010-09-10 | 2014-01-20 | 京都薬品工業株式会社 | 複素環化合物 |
| CN102807526B (zh) * | 2011-06-21 | 2015-12-02 | 寿光富康制药有限公司 | 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用 |
| WO2020013116A1 (ja) * | 2018-07-10 | 2020-01-16 | 京都薬品工業株式会社 | Ｐｔｐ－１ｂ阻害剤およびその用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| AU3719997A (en) | 1996-07-01 | 1998-01-21 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
| AU3513497A (en) * | 1996-07-01 | 1998-01-21 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
| GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| WO2001040192A1 (fr) * | 1999-12-03 | 2001-06-07 | Kyoto Pharmaceutical Industries, Ltd. | Nouveaux composes heterocycliques et sels de ces derniers, utilisations de ces composes en medecine |
| US20020037897A1 (en) * | 2000-08-07 | 2002-03-28 | 3-Dimensional Pharmaceuticals, Inc. | Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists |
| HUP0400023A2 (hu) * | 2001-05-29 | 2004-04-28 | Kyoto Pharmaceutical Industries, Ltd. | Új heterociklusos származékok és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
-
2002
- 2002-05-27 US US10/478,862 patent/US7557123B2/en not_active Expired - Fee Related
- 2002-05-27 MX MXPA03010811A patent/MXPA03010811A/es active IP Right Grant
- 2002-05-27 IL IL15908502A patent/IL159085A0/xx unknown
- 2002-05-27 JP JP2003500060A patent/JP4279136B2/ja not_active Expired - Fee Related
- 2002-05-27 NZ NZ530358A patent/NZ530358A/en unknown
- 2002-05-27 CN CNB028109643A patent/CN1242994C/zh not_active Expired - Fee Related
- 2002-05-27 EP EP02774070A patent/EP1403253A4/en not_active Withdrawn
- 2002-05-27 YU YU94003A patent/YU94003A/sh unknown
- 2002-05-27 RU RU2003137574/04A patent/RU2299197C2/ru not_active IP Right Cessation
- 2002-05-27 PL PL02367639A patent/PL367639A1/xx unknown
- 2002-05-27 WO PCT/JP2002/005097 patent/WO2002096880A1/ja active Application Filing
- 2002-05-27 CA CA002448634A patent/CA2448634A1/en not_active Abandoned
- 2002-05-27 ZA ZA200309757A patent/ZA200309757B/en unknown
- 2002-05-27 AU AU2002308889A patent/AU2002308889B2/en not_active Ceased
- 2002-05-27 KR KR10-2003-7015611A patent/KR20040030647A/ko not_active Withdrawn
- 2002-05-27 KR KR1020087023698A patent/KR100898358B1/ko not_active Expired - Fee Related
- 2002-05-27 HU HU0401862A patent/HUP0401862A3/hu unknown
- 2002-05-27 CZ CZ20033450A patent/CZ20033450A3/cs unknown
- 2002-05-27 BR BR0209711-7A patent/BR0209711A/pt not_active IP Right Cessation
- 2002-05-28 TW TW091111315A patent/TWI297008B/zh active
- 2002-05-29 AR ARP020102002A patent/AR036036A1/es unknown
-
2003
- 2003-11-28 NO NO20035331A patent/NO326688B1/no not_active IP Right Cessation
- 2003-12-29 CO CO03112806A patent/CO5540342A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI297008B (en) | 2008-05-21 |
| HUP0401862A3 (en) | 2009-03-30 |
| YU94003A (sh) | 2006-08-17 |
| NO326688B1 (no) | 2009-01-26 |
| HUP0401862A2 (hu) | 2004-12-28 |
| CN1242994C (zh) | 2006-02-22 |
| PL367639A1 (en) | 2005-03-07 |
| CN1527819A (zh) | 2004-09-08 |
| KR20080093076A (ko) | 2008-10-17 |
| WO2002096880A1 (fr) | 2002-12-05 |
| EP1403253A1 (en) | 2004-03-31 |
| RU2003137574A (ru) | 2005-05-20 |
| KR20040030647A (ko) | 2004-04-09 |
| BR0209711A (pt) | 2004-11-03 |
| MXPA03010811A (es) | 2004-02-27 |
| KR100898358B1 (ko) | 2009-05-20 |
| US20040220215A1 (en) | 2004-11-04 |
| HK1069385A1 (en) | 2005-05-20 |
| RU2299197C2 (ru) | 2007-05-20 |
| AR036036A1 (es) | 2004-08-04 |
| CA2448634A1 (en) | 2002-12-05 |
| NZ530358A (en) | 2005-04-29 |
| CZ20033450A3 (cs) | 2004-05-12 |
| JP4279136B2 (ja) | 2009-06-17 |
| ZA200309757B (en) | 2004-12-22 |
| CO5540342A2 (es) | 2005-07-29 |
| US7557123B2 (en) | 2009-07-07 |
| EP1403253A4 (en) | 2005-03-30 |
| AU2002308889B2 (en) | 2007-09-06 |
| JPWO2002096880A1 (ja) | 2004-09-09 |
| IL159085A0 (en) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
| NO20042147L (no) | Heterocykliske forbindelser og fremgangsmater for anvendelse derav | |
| NO20040469L (no) | Heterocykliske forbindelser samt fremstilling og anvendelse derav | |
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| NO20041872L (no) | Esterforbindelser og medisinsk anvendelse derav | |
| NO20055246D0 (no) | Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav | |
| NO20022600D0 (no) | Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme | |
| NO20014135L (no) | Nye sulfonamidforbindelser og deres anvendelse | |
| NO20022289L (no) | Ny anvendelse og nye N-azabisykloamidderivater | |
| DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
| NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
| NO20033002L (no) | Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme | |
| NO20033203D0 (no) | Terapeutiske heterocykliske forbindelser | |
| IS8392A (is) | Heterósýklískir hindrar MEK og notkun þeirra | |
| DK1578755T3 (da) | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse | |
| DK1429769T3 (da) | Nye formuleringer og anvendelse deraf | |
| DK1537096T3 (da) | Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf | |
| NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
| DK1513835T3 (da) | Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf | |
| DK1590321T3 (da) | Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf | |
| IS2482B (is) | Arómatísk súlfón og læknisfræðileg notkun þeirra | |
| DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
| NO20035332D0 (no) | Nye heterocykliske derivater og medisinsk anvendelse derav | |
| NO20052124D0 (no) | Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse | |
| DK1556382T3 (da) | 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |